BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 23423256)

  • 1. Macrophages promote polycystic kidney disease progression.
    Swenson-Fields KI; Vivian CJ; Salah SM; Peda JD; Davis BM; van Rooijen N; Wallace DP; Fields TA
    Kidney Int; 2013 May; 83(5):855-64. PubMed ID: 23423256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myofibroblast depletion reduces kidney cyst growth and fibrosis in autosomal dominant polycystic kidney disease.
    Dwivedi N; Jamadar A; Mathew S; Fields TA; Rao R
    Kidney Int; 2023 Jan; 103(1):144-155. PubMed ID: 36273656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Macrophages and Cyst-Lining Epithelial Cells Promote Kidney Cyst Growth in
    Yang Y; Chen M; Zhou J; Lv J; Song S; Fu L; Chen J; Yang M; Mei C
    J Am Soc Nephrol; 2018 Sep; 29(9):2310-2325. PubMed ID: 30042193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
    Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
    Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cilia and polycystic kidney disease.
    Ma M
    Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease.
    Raman A; Parnell SC; Zhang Y; Reif GA; Dai Y; Khanna A; Daniel E; White C; Vivian JL; Wallace DP
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1695-F1707. PubMed ID: 30332313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD.
    Vijayakumar S; Dang S; Marinkovich MP; Lazarova Z; Yoder B; Torres VE; Wallace DP
    Am J Physiol Renal Physiol; 2014 Mar; 306(6):F640-54. PubMed ID: 24370592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the
    Hama T; Nakanishi K; Sato M; Mukaiyama H; Togawa H; Shima Y; Miyajima M; Nozu K; Nagao S; Takahashi H; Sako M; Iijima K; Yoshikawa N; Suzuki H
    Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1223-F1231. PubMed ID: 28877884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.
    Yamaguchi T; Hempson SJ; Reif GA; Hedge AM; Wallace DP
    J Am Soc Nephrol; 2006 Jan; 17(1):178-87. PubMed ID: 16319189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of TGF-β1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease.
    Zhang Y; Dai Y; Raman A; Daniel E; Metcalf J; Reif G; Pierucci-Alves F; Wallace DP
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1135-F1148. PubMed ID: 33166182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease.
    Ding H; Li LX; Harris PC; Yang J; Li X
    Nat Commun; 2021 Jul; 12(1):4548. PubMed ID: 34315885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of autosomal recessive polycystic kidney disease in BALB/c-cpk/cpk mice.
    Ricker JL; Gattone VH; Calvet JP; Rankin CA
    J Am Soc Nephrol; 2000 Oct; 11(10):1837-1847. PubMed ID: 11004214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease.
    Wang X; Harris PC; Somlo S; Batlle D; Torres VE
    Nephrol Dial Transplant; 2009 Feb; 24(2):526-34. PubMed ID: 18826972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
    Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X
    J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
    Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
    J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apico-basal polarity in polycystic kidney disease epithelia.
    Wilson PD
    Biochim Biophys Acta; 2011 Oct; 1812(10):1239-48. PubMed ID: 21658447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Hippo signalling in polycystic kidney disease.
    Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8
    Kleczko EK; Marsh KH; Tyler LC; Furgeson SB; Bullock BL; Altmann CJ; Miyazaki M; Gitomer BY; Harris PC; Weiser-Evans MCM; Chonchol MB; Clambey ET; Nemenoff RA; Hopp K
    Kidney Int; 2018 Dec; 94(6):1127-1140. PubMed ID: 30249452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystogenesis in ARPKD results from increased apoptosis in collecting duct epithelial cells of Pkhd1 mutant kidneys.
    Hu B; He X; Li A; Qiu Q; Li C; Liang D; Zhao P; Ma J; Coffey RJ; Zhan Q; Wu G
    Exp Cell Res; 2011 Jan; 317(2):173-87. PubMed ID: 20875407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyst expansion and regression in a mouse model of polycystic kidney disease.
    Happé H; van der Wal AM; Salvatori DC; Leonhard WN; Breuning MH; de Heer E; Peters DJ
    Kidney Int; 2013 Jun; 83(6):1099-108. PubMed ID: 23466997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.